WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia in 14 fonti

Moderna entwickelt Impfstoff gegen Ebola-Variante

Der US-Pharmakonzern will mit Unterstützung der internationalen Impfallianz CEPI einen Impfstoff gegen das Bundibugyo-Ebolavirus herstellen. Diese Ebola-Variante verbreitet sich gerade in Afrika.© SZ - Rechte am Artikel können Sie hier erwerben.Lesen Sie mehr zum ThemaVideo

Raccontata da

independent.co.uk

it.euronews.com

koreatimes.co.kr

oglobo.globo.com

sueddeutsche.de

arstechnica.com

thejakartapost.com

nation.africa+2 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

sueddeutsche.deStai leggendo1 mesi fa

Moderna entwickelt Impfstoff gegen Ebola-Variante

Der US-Pharmakonzern will mit Unterstützung der internationalen Impfallianz CEPI einen Impfstoff gegen das Bundibugyo-Ebolavirus herstellen. Diese Ebola-Variante verbreitet sich gerade in Afrika.© SZ - Rechte am Artikel…

Timeline cronologica

lunedì 1 giugno 2026·independent.co.uk
Moderna receives $50 million to develop Ebola vaccine as number of cases surge
This initiative is crucial as health authorities worldwide race to identify medical options and contain the outbreak, which has seen over 900 suspected cases and more than 220…
lunedì 1 giugno 2026·it.euronews.com
Autorità sanitaria accelera tre vaccini anti Ebola in piena diffusione
L’ente globale per la salute CEPI sta accelerando lo sviluppo di tre vaccini sperimentali contro il ceppo Bundibugyo dell’Ebola, mentre il focolaio in Africa centrale continua a…

1 mesi fa

Internationale Geldgeber investieren Millionen in Ebolaimpfstoffe

Die Zahl der Ebolainfizierten in Zentralafrika wächst. Im Kampf gegen die tödliche Krankheit bekommen Firmen und Forscher nun Finanzhilfen, ein großer Betrag geht an den US-Hersteller Moderna.

Leggi questa versione → originale

arabnews.com1 mesi fa

Moderna and other groups get $60m to develop Ebola vaccine

CEPI funds Moderna, Oxford, IAVI with $60M for Ebola Bundibugyo trials in two months, addressing 282+ DRC cases. mRNA platform reuse compresses vaccine cycles from years to months—a governance model for infrastructure agility under crisis.

Leggi questa versione → originale

arstechnica.com1 mesi fa

Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo

Amid a raging Ebola outbreak, officials "urgently accelerate development" of vaccines.

Leggi questa versione → originale

independent.co.uk1 mesi fa

Moderna receives $50 million to develop Ebola vaccine as number of cases surge

This initiative is crucial as health authorities worldwide race to identify medical options and contain the outbreak, which has seen over 900 suspected cases and more than 220 suspected deaths

Leggi questa versione → originale

thejakartapost.com1 mesi fa

Moderna and other groups get $60 million to develop Ebola vaccine - Middle East and Africa - The Jakarta Post

CEPI allocated $60M to Moderna and partners for rapid Ebola Bundibugyo vaccine development with trials within months. The pace tests pandemic-era platform scalability while revealing manufacturing and trial logistics as the critical constraint for emergency response deployment.

Leggi questa versione → originale

lunedì 1 giugno 2026·

euronews.com

Health body fast-tracks three Ebola vaccines as virus continues spread

Global health body CEPI is fast-tracking three experimental vaccines against the Bundibugyo strain of Ebola as the outbreak in Central Africa continues to spread.

lunedì 1 giugno 2026·

it.euronews.com

Autorità sanitaria accelera tre vaccini anti Ebola

L’ente globale per la salute CEPI sta accelerando lo sviluppo di vaccini sperimentali contro il ceppo Bundibugyo dell’Ebola. Il focolaio in Africa centrale continua a propagarsi

lunedì 1 giugno 2026·

qz.com

Moderna partners with CEPI on Bundibugyo Ebola vaccine

CEPI is committing up to $50 million to support Moderna's vaccine candidate for the strain with no approved shot

lunedì 1 giugno 2026·

koreatimes.co.kr

Moderna and other groups get $60 million to develop Ebola vaccine - The Korea Times

Global health organisation CEPI will give roughly $60 million to Moderna and to two other groups to accelerate the development of shots against Ebo...

lunedì 1 giugno 2026·

g1.globo.com

Vacina contra ebola: Moderna desenvolve imunizante para cepa rara | G1

Parceria entre Moderna e CEPI foca em vacina contra a cepa Bundibugyo do ebola, enquanto a OMS prioriza imunizantes experimentais para conter surto no Congo.

lunedì 1 giugno 2026·

oglobo.globo.com

Moderna faz parceria com coalizão global de saúde para desenvolver vacina contra o Ebola Bundibugyo

Doença já registrou cerca de 900 casos suspeitos e mais de 220 mortes suspeitas

lunedì 1 giugno 2026·

sueddeutsche.de

Moderna entwickelt Impfstoff gegen Ebola-Variante

Der US-Pharmakonzern will mit Unterstützung der internationalen Impfallianz CEPI einen Impfstoff gegen das Bundibugyo-Ebolavirus herstellen. Diese Ebola-Variante verbreitet sich…

lunedì 1 giugno 2026·

arabnews.com

Moderna and other groups get $60m to develop Ebola vaccine

BENGALURU: Global health organization CEPI will give roughly $60 million to Moderna and to two other groups to accelerate the development of shots against Ebola Bundibugyo, the…

lunedì 1 giugno 2026·

arstechnica.com

Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo

Amid a raging Ebola outbreak, officials "urgently accelerate development" of vaccines.

martedì 2 giugno 2026·

thejakartapost.com

Moderna and other groups get $60 million to develop Ebola vaccine - Middle East and Africa - The Jakarta Post

The Coalition for Epidemic Preparedness Innovations was one of the early investors that helped to develop a vaccine at the height of the COVID-19 pandemic.

martedì 2 giugno 2026·

nation.africa

Scientists target human trials for new Ebola vaccine 'within months'

This funding surge aims to fast-track vaccine candidates against the deadly Ebola Bundibugyo strain.

martedì 2 giugno 2026·

spiegel.de

Internationale Geldgeber investieren Millionen in Ebolaimpfstoffe

Die Zahl der Ebolainfizierten in Zentralafrika wächst. Im Kampf gegen die tödliche Krankheit bekommen Firmen und Forscher nun Finanzhilfen, ein großer Betrag geht an den…

martedì 2 giugno 2026·

tagesschau.de

So weit ist die Forschung zu Ebola-Impfstoffen

In der Demokratischen Republik Kongo und in Uganda breitet sich das Ebola-Virus weiter aus. Genau genommen: der seltene Bundibugyo-Stamm. Dagegen gibt es bisher weder Impfstoffe…